Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

pollyvonwog,

From NVS PR

"Biopharmaceuticals (which include biosimilars, biopharmaceutical contract manufacturing and Glatopa) grew 28% (cc) to USD 186 million, including continued progress of the newly launched Glatopa.”

They seem to think Glatopa is having continued progress. Now I am anxious to hear how much we earned.

The only thing I can think of is, improving over the actual sales after the initial stocking.

Boing X 2